PapersFlow Research Brief
Cytomegalovirus and herpesvirus research
Research Guide
What is Cytomegalovirus and herpesvirus research?
Cytomegalovirus and herpesvirus research is the study of the epidemiology, management, and immunological impacts of cytomegalovirus (CMV) infections, with a focus on transplant recipients, congenitally infected individuals, antiviral therapies, vaccine development, T cell responses, hearing loss associations, and viral immune evasion strategies.
This field encompasses 87,051 published works on CMV and related herpesviruses. Research targets CMV infections in high-risk groups such as transplant recipients and immunocompromised individuals. Key areas include antiviral therapy efficacy, vaccine candidates, and CMV-linked congenital hearing loss.
Topic Hierarchy
Research Sub-Topics
Cytomegalovirus in Transplant Recipients
Studies epidemiology, risk stratification, and outcomes of CMV infection in solid organ and hematopoietic stem cell transplant patients, including preemptive therapy and prophylaxis efficacy. Researchers evaluate viral load monitoring and resistance mutations.
Congenital Cytomegalovirus Infection
Investigates maternal-fetal transmission, neonatal diagnostics, neurodevelopmental sequelae like hearing loss, and long-term outcomes. Trials assess antiviral interventions and screening protocols for pregnant women.
Cytomegalovirus Antiviral Therapy
Evaluates ganciclovir, valganciclovir, foscarnet, and novel agents for treatment efficacy, pharmacokinetics in immunocompromised hosts, and resistance profiling. Research explores combination therapies and immune reconstitution.
CMV-Specific T Cell Immunity
Analyzes CD8+ and CD4+ T cell responses, epitope mapping, polyfunctionality, and exhaustion markers using tetramers and ICS assays. Studies adoptive T cell therapies and vaccine-induced cellular immunity.
Cytomegalovirus Immune Evasion Mechanisms
Elucidates viral genes (UL18, UL40, pp65) modulating MHC-I/II presentation, NK cell inhibition, and cytokine signaling. Functional studies use CRISPR-edited mutants to dissect pathogenesis.
Why It Matters
Cytomegalovirus research addresses critical needs in transplant medicine, where CMV infections increase graft rejection risks and mortality in recipients. Studies like "Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men" by Gottlieb et al. (1981) documented CMV recovery from secretions in four patients with opportunistic infections, highlighting its role in immunocompromised states. In congenital cases, CMV associates with sensorineural hearing loss, informing screening and intervention protocols. Discoveries such as herpesvirus-like DNA sequences in "Identification of Herpesvirus-Like DNA Sequences in AIDS-Associated Kaposi's Sarcoma" by Chang et al. (1994), present in over 90% of AIDS-related Kaposi's sarcoma tissues, link herpesviruses to oncogenesis in HIV patients. These findings support targeted antiviral therapies and vaccine trials to reduce morbidity in vulnerable populations.
Reading Guide
Where to Start
"Identification of Herpesvirus-Like DNA Sequences in AIDS-Associated Kaposi's Sarcoma" by Chang et al. (1994), as it provides a foundational method for detecting herpesvirus DNA in diseased tissues using representational difference analysis, offering accessible entry into viral epidemiology.
Key Papers Explained
"Multiplex Genome Engineering Using CRISPR/Cas Systems" by Cong et al. (2013) establishes CRISPR tools for precise genome editing, potentially applicable to CMV studies (15,339 citations). "Identification of Herpesvirus-Like DNA Sequences in AIDS-Associated Kaposi's Sarcoma" by Chang et al. (1994) builds detection methods for herpesvirus DNA in tumors (5,670 citations), linking to immune contexts. "Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men" by Gottlieb et al. (1981) documents CMV in opportunistic infections (2,695 citations), connecting clinical observations to viral roles.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current efforts center on T cell responses and vaccine development for CMV in transplants and congenital cases, per the field's 87,051 papers. No recent preprints or news available; frontiers involve applying CRISPR from "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013) to model immune evasion.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Multiplex Genome Engineering Using CRISPR/Cas Systems | 2013 | Science | 15.3K | ✕ |
| 2 | Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssoc... | 1994 | Science | 5.7K | ✕ |
| 3 | Selective extraction of polyoma DNA from infected mouse cell c... | 1967 | Journal of Molecular B... | 5.3K | ✕ |
| 4 | CpG motifs in bacterial DNA trigger direct B-cell activation | 1995 | Nature | 3.5K | ✕ |
| 5 | Toxoplasmosis | 2004 | The Lancet | 3.2K | ✕ |
| 6 | Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-... | 1995 | Science | 2.9K | ✕ |
| 7 | Cancer Regression and Autoimmunity in Patients After Clonal Re... | 2002 | Science | 2.8K | ✓ |
| 8 | <i>Pneumocystis carinii</i>Pneumonia and Mucosal Candidiasis i... | 1981 | New England Journal of... | 2.7K | ✕ |
| 9 | An updated evolutionary classification of CRISPR–Cas systems | 2015 | Nature Reviews Microbi... | 2.5K | ✓ |
| 10 | CRISPR/Cas, the Immune System of Bacteria and Archaea | 2010 | Science | 2.4K | ✕ |
Frequently Asked Questions
What role does CMV play in transplant recipients?
CMV infections in transplant recipients elevate risks of graft rejection and overall mortality. Research focuses on antiviral therapies to manage these infections in immunocompromised individuals. Management strategies aim to prevent reactivation and dissemination.
How is CMV associated with congenital infections?
Congenital CMV infection links to hearing loss in affected infants. Studies examine epidemiological patterns and long-term outcomes in these cases. Early detection supports interventions to mitigate developmental impacts.
What are the main immune responses studied in CMV research?
T cell responses form a central focus, countering CMV immune evasion tactics. Investigations detail how CD8+ T cells produce suppressive factors against related viruses. These responses inform vaccine development efforts.
What methods are used to study herpesvirus DNA in tissues?
Representational difference analysis isolated herpesvirus-like DNA sequences in over 90% of AIDS-associated Kaposi's sarcoma tissues, as shown in "Identification of Herpesvirus-Like DNA Sequences in AIDS-Associated Kaposi's Sarcoma" (1994). Such techniques distinguish viral DNA from host sequences. They enable detection in immunocompromised patients.
How do herpesviruses appear in opportunistic infections?
In "Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men" (1981), CMV was recovered from secretions in all four patients with Pneumocystis pneumonia and candidiasis. This underscores CMV prevalence in early AIDS cases. It guides diagnostic vigilance in similar cohorts.
What is the scope of papers in this field?
The field includes 87,051 works on CMV epidemiology and herpesvirus impacts. Coverage spans transplant management, congenital effects, and immune strategies. No 5-year growth rate data is specified.
Open Research Questions
- ? How can antiviral therapies be optimized to overcome CMV immune evasion in transplant recipients?
- ? What T cell response mechanisms best protect against congenital CMV hearing loss?
- ? Which vaccine designs effectively target CMV in immunocompromised individuals?
- ? How do herpesvirus DNA sequences contribute to oncogenesis in AIDS patients?
- ? What factors drive CMV reactivation patterns post-transplantation?
Recent Trends
The field maintains 87,051 papers with no specified 5-year growth rate.
High-citation works like "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013, 15,339 citations) indicate sustained interest in genome tools for herpesvirus studies.
No recent preprints or news reported.
Research Cytomegalovirus and herpesvirus research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cytomegalovirus and herpesvirus research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers